SCHEMBL1744162

SCHEMBL1744162

CSC[C@H](c1ccc(C(F)(F)F)cc1)[C@H](COC(=O)C(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE2A O00408 2/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
FFAR1 O14842 3/20 0.33
GSK3B P49841 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCD Q05655 1/20 0.33
CYP26A1 O43174 1/20 0.32
LDHA P00338 1/20 0.32
LDHB P07195 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
PDPK1 O15530 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1744164 1.00 PPARG (0.38) PPARGPPARAALDH1A1L3MBTL1PDE2A
SCHEMBL1744160 1.00 PPARG (0.38) PPARGPPARAALDH1A1L3MBTL1PDE2A
SCHEMBL1743782 0.88 PRKCA (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1743778 0.88 PRKCA (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1743781 0.88 PRKCA (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1743817 0.87 ALDH1A1 (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1743820 0.87 ALDH1A1 (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1743821 0.87 ALDH1A1 (0.38) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1595149 0.84 PRKCA (0.41) PPARGPPARAALDH1A1L3MBTL1CES2
SCHEMBL1595147 0.84 PRKCA (0.41) PPARGPPARAALDH1A1L3MBTL1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 PPARG 232/4885PPARA 896/4885ALDH1A1 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.